Cargando…

Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI

SIMPLE SUMMARY: Colorectal cancer is one of the most frequent cancers worldwide, with a high incidence and mortality. Although many treatment options are available for metastatic disease, patient survival is still limited. The molecular classification of colorectal cancer proposed in 2015 has helped...

Descripción completa

Detalles Bibliográficos
Autores principales: Volovat, Simona-Ruxandra, Augustin, Iolanda, Zob, Daniela, Boboc, Diana, Amurariti, Florin, Volovat, Constantin, Stefanescu, Cipriana, Stolniceanu, Cati Raluca, Ciocoiu, Manuela, Dumitras, Eduard Alexandru, Danciu, Mihai, Apostol, Delia Gabriela Ciobanu, Drug, Vasile, Shurbaji, Sinziana Al, Coca, Lucia-Georgiana, Leon, Florin, Iftene, Adrian, Herghelegiu, Paul-Corneliu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562853/
https://www.ncbi.nlm.nih.gov/pubmed/36230757
http://dx.doi.org/10.3390/cancers14194834
_version_ 1784808268001968128
author Volovat, Simona-Ruxandra
Augustin, Iolanda
Zob, Daniela
Boboc, Diana
Amurariti, Florin
Volovat, Constantin
Stefanescu, Cipriana
Stolniceanu, Cati Raluca
Ciocoiu, Manuela
Dumitras, Eduard Alexandru
Danciu, Mihai
Apostol, Delia Gabriela Ciobanu
Drug, Vasile
Shurbaji, Sinziana Al
Coca, Lucia-Georgiana
Leon, Florin
Iftene, Adrian
Herghelegiu, Paul-Corneliu
author_facet Volovat, Simona-Ruxandra
Augustin, Iolanda
Zob, Daniela
Boboc, Diana
Amurariti, Florin
Volovat, Constantin
Stefanescu, Cipriana
Stolniceanu, Cati Raluca
Ciocoiu, Manuela
Dumitras, Eduard Alexandru
Danciu, Mihai
Apostol, Delia Gabriela Ciobanu
Drug, Vasile
Shurbaji, Sinziana Al
Coca, Lucia-Georgiana
Leon, Florin
Iftene, Adrian
Herghelegiu, Paul-Corneliu
author_sort Volovat, Simona-Ruxandra
collection PubMed
description SIMPLE SUMMARY: Colorectal cancer is one of the most frequent cancers worldwide, with a high incidence and mortality. Although many treatment options are available for metastatic disease, patient survival is still limited. The molecular classification of colorectal cancer proposed in 2015 has helped us to better understand colorectal cancer and realize a more effective implementation of therapeutic sequences. It has also been observed that the existing mutational landscape is closely correlated with the epigenetics of colorectal cancer. The identification of prognostic and predictive biomarkers in this context becomes a necessity closely related to therapeutics, and artificial intelligence can be used to discover new biomarkers. ABSTRACT: Colorectal cancer is a major cause of cancer-related death worldwide and is correlated with genetic and epigenetic alterations in the colonic epithelium. Genetic changes play a major role in the pathophysiology of colorectal cancer through the development of gene mutations, but recent research has shown an important role for epigenetic alterations. In this review, we try to describe the current knowledge about epigenetic alterations, including DNA methylation and histone modifications, as well as the role of non-coding RNAs as epigenetic regulators and the prognostic and predictive biomarkers in metastatic colorectal disease that can allow increases in the effectiveness of treatments. Additionally, the intestinal microbiota’s composition can be an important biomarker for the response to strategies based on the immunotherapy of CRC. The identification of biomarkers in mCRC can be enhanced by developing artificial intelligence programs. We present the actual models that implement AI technology as a bridge connecting ncRNAs with tumors and conducted some experiments to improve the quality of the model used as well as the speed of the model that provides answers to users. In order to carry out this task, we implemented six algorithms: the naive Bayes classifier, the random forest classifier, the decision tree classifier, gradient boosted trees, logistic regression and SVM.
format Online
Article
Text
id pubmed-9562853
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95628532022-10-15 Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI Volovat, Simona-Ruxandra Augustin, Iolanda Zob, Daniela Boboc, Diana Amurariti, Florin Volovat, Constantin Stefanescu, Cipriana Stolniceanu, Cati Raluca Ciocoiu, Manuela Dumitras, Eduard Alexandru Danciu, Mihai Apostol, Delia Gabriela Ciobanu Drug, Vasile Shurbaji, Sinziana Al Coca, Lucia-Georgiana Leon, Florin Iftene, Adrian Herghelegiu, Paul-Corneliu Cancers (Basel) Review SIMPLE SUMMARY: Colorectal cancer is one of the most frequent cancers worldwide, with a high incidence and mortality. Although many treatment options are available for metastatic disease, patient survival is still limited. The molecular classification of colorectal cancer proposed in 2015 has helped us to better understand colorectal cancer and realize a more effective implementation of therapeutic sequences. It has also been observed that the existing mutational landscape is closely correlated with the epigenetics of colorectal cancer. The identification of prognostic and predictive biomarkers in this context becomes a necessity closely related to therapeutics, and artificial intelligence can be used to discover new biomarkers. ABSTRACT: Colorectal cancer is a major cause of cancer-related death worldwide and is correlated with genetic and epigenetic alterations in the colonic epithelium. Genetic changes play a major role in the pathophysiology of colorectal cancer through the development of gene mutations, but recent research has shown an important role for epigenetic alterations. In this review, we try to describe the current knowledge about epigenetic alterations, including DNA methylation and histone modifications, as well as the role of non-coding RNAs as epigenetic regulators and the prognostic and predictive biomarkers in metastatic colorectal disease that can allow increases in the effectiveness of treatments. Additionally, the intestinal microbiota’s composition can be an important biomarker for the response to strategies based on the immunotherapy of CRC. The identification of biomarkers in mCRC can be enhanced by developing artificial intelligence programs. We present the actual models that implement AI technology as a bridge connecting ncRNAs with tumors and conducted some experiments to improve the quality of the model used as well as the speed of the model that provides answers to users. In order to carry out this task, we implemented six algorithms: the naive Bayes classifier, the random forest classifier, the decision tree classifier, gradient boosted trees, logistic regression and SVM. MDPI 2022-10-03 /pmc/articles/PMC9562853/ /pubmed/36230757 http://dx.doi.org/10.3390/cancers14194834 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Volovat, Simona-Ruxandra
Augustin, Iolanda
Zob, Daniela
Boboc, Diana
Amurariti, Florin
Volovat, Constantin
Stefanescu, Cipriana
Stolniceanu, Cati Raluca
Ciocoiu, Manuela
Dumitras, Eduard Alexandru
Danciu, Mihai
Apostol, Delia Gabriela Ciobanu
Drug, Vasile
Shurbaji, Sinziana Al
Coca, Lucia-Georgiana
Leon, Florin
Iftene, Adrian
Herghelegiu, Paul-Corneliu
Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI
title Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI
title_full Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI
title_fullStr Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI
title_full_unstemmed Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI
title_short Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI
title_sort use of personalized biomarkers in metastatic colorectal cancer and the impact of ai
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562853/
https://www.ncbi.nlm.nih.gov/pubmed/36230757
http://dx.doi.org/10.3390/cancers14194834
work_keys_str_mv AT volovatsimonaruxandra useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT augustiniolanda useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT zobdaniela useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT bobocdiana useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT amuraritiflorin useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT volovatconstantin useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT stefanescucipriana useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT stolniceanucatiraluca useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT ciocoiumanuela useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT dumitraseduardalexandru useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT danciumihai useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT apostoldeliagabrielaciobanu useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT drugvasile useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT shurbajisinzianaal useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT cocaluciageorgiana useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT leonflorin useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT ifteneadrian useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai
AT herghelegiupaulcorneliu useofpersonalizedbiomarkersinmetastaticcolorectalcancerandtheimpactofai